Sorry, you need to enable JavaScript to visit this website.

Season 1 of Science Will Win is a four-part miniseries exploring the science behind gene therapy; the next generation of medicines which could bring new possibilities for patients living with rare genetic diseases.

Listeners will hear from a diverse line-up of leading experts on the future-shaping science, challenging policy environment and the personal stories which remain our guiding-light in the search for breakthrough therapies of tomorrow.

At a time when innovative science is achieving the seemingly impossible, we’ll look at gene therapy from every angle, speaking to the Pfizer scientists and experts on the forefront of medical research, as well as the patients and families who are holding new hope in the life-changing potential of gene therapy.

Subscribe and follow Science Will Win to make sure you don’t miss an episode.

applespotify

Host

adam rutherford
© Stefan Oboski

Season 1 of Science Will Win is hosted by Adam Rutherford, a geneticist, writer, broadcaster and Honorary Fellow at University College London (UCL), U.K. After studying evolutionary biology at UCL, Adam gained a PhD from Great Ormond St Hospital and the Institute of Child Health, London, in the genetics of the developing eye and was also part of the team that identified the first genetic cause of a form of childhood blindness. Since then, Adam spent ten years as an editor for the science journal, Nature, as well as writing and featuring in an array of BBC television, radio and podcast programmes.

Science Will Win is a podcast that takes listeners under the microscope of some the most promising medical innovations, exploring therapies which have the potential to shape the future of healthcare and offer new hope to patients around the world.

Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates and, most importantly, patients themselves, each miniseries focuses on a unique healthcare challenge, diving into the fascinating science, policy challenges and potential to transform patients’ lives for the better.

This podcast is powered by Pfizer. The information, statements, comments, views and opinions expressed by those guests featured in this podcast are their own and not necessarily representative of the views and opinions of Pfizer Inc.

The Antigen Podcast

  • The Antigen is an eight-part audio-documentary style podcast about the scientific, cultural, and political elements of vaccination. We start with the basic science, review vaccine history, explore the many facets of their global impact, and the public sentiment about vaccines around the world. Hear from leading experts about the past, present, and future of this important innovation, as well as people whose families have been impacted by vaccine-preventable diseases. Host: Jasmeen Agosti M.D., pediatrician and part of Pfizer’s Viral Vaccines Medical Group

    Podcastspotify

    See the full transcript for Episode 1 here

    See the full transcript for Episode 2 here

    See the full transcript for Episode 3 here

    See the full transcript for Episode 4 here

    See the full transcript for Episode 5 here

    See the full transcript for Episode 6 here

    See the full transcript for Episode 7 here

    See the full transcript for Episode 8 here

    Host

    Host season1Season 1 of The Antigen is hosted by Yasmeen Agosti, MD FAAP. Yasmeen is a pediatrician and a Global Medical Lead, Viral Vaccines at Pfizer. She is a Ph.D. candidate in Clinical Microbiology and Infectious Diseases at the University of Witwatersrand. Yasmeen trained as a general pediatrician in Philadelphia and, later, conducted clinical research on respiratory syncytial virus in South Africa as part of her doctoral studies. She joined Pfizer in 2017. Learn more about her background and current work at Pfizer.

    *Guests have not been compensated for their participation on this podcast.

  • The Antigen is back with a special mini-series focused on COVID-19, connecting with experts to give accurate information and updates on the global response to the pandemic. Over the course of the mini-series, we will look back at past global health emergencies, discuss efforts across the industry to research potential coronavirus vaccines and treatments, and look ahead to life after a crisis. Host: Lindsey Dietschi, Pfizer Global Health Partnerships Lead

    Podcastspotify

    See the full transcript for Episode 1 here

    See the full transcript for Episode 2 here

    See the full transcript for Episode 3 here

    See the full transcript for Episode 4 here

    Host

    Host season2

    The Antigen: #COVID19 mini-series is hosted by Lindsey Dietschi. As the Vice President, Global Health Partnerships Lead in Pfizer's Emerging Markets, Lindsey leads a team that establishes partnerships to bring Pfizer medicines and vaccines to people in Africa, Asia, and Latin America. She has worked at Pfizer for nearly 17 years and in vaccines for more than 10 years, including serving as the representative of the developed world vaccine manufacturers on the Programme and Policy Committee of Gavi, the Vaccine Alliance. Lindsey has a Bachelor of Arts from Michigan State University and Master of Business Administration from the Stern School of Business at New York University, where she is also currently an Adjunct Professor in the Management Communications department.

    *Guests have not been compensated for their participation on this podcast

Diverse Perspectives is a series of short, one-to-one interviews with thought leaders who are pioneering change across a variety of industries. From applying simplicity principles at work to delivering medicines by drone, host Angela Hwang of Pfizer invites guests to share their ‘innovation mindset’ and what motivates them to create positive change in the world.

Host

angela hwang

Diverse Perspectives is hosted by Angela Hwang, Group President of the Pfizer Biopharmaceuticals Group and a member of the company’s Executive Leadership Team. She leads all of Pfizer’s innovative medicines businesses; a global organization that operates in more than 125 countries, with a portfolio of more than 600 products generating approximately $38 billion in 2018 revenues for Pfizer. Learn more about Angela.

Hemcast is a Pfizer podcast series designed to keep clinical care teams, patients, and members of the public informed regarding scientific, technological, and clinical advances in hemophilia.

Hosted by Pfizer’s Dr Ian Winburn, listeners will hear from a range of experienced health care practitioners and patients, who will share their insights into hemophilia care, now and in the future.

Menopause: unmuted is a podcast series exploring first-hand experiences of this life stage. Honest, hopeful and life affirming, the podcast features women talking candidly about their menopause, and its impact on relationships, friends, family, and work. For some women menopause can be tough, and for others it’s a time of liberation. Each episode shares deeply personal accounts of the different emotional and physical symptoms experienced. Often funny, always forthright, these women offer us inspiration and insight. Leading women’s health expert Dr. Mary Jane Minkin hosts the podcast. Listening in, she provides an expert perspective, busting myths and offering evidence-based advice. menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option. Podcast powered by Pfizer.

menopause_unmuted_glossary_of_terms.jpgmenopause_unmuted_menopause_discussion_guide.jpgmenopause_unmuted_talking_about_menopause.jpgmindsets_on_menopause_300X232.jpg

Download PDF

Download PDF

Download PDF

Download PDF